Status:

COMPLETED

BIOTRONIK Conduction System Pacing With the Solia Lead

Lead Sponsor:

Biotronik, Inc.

Conditions:

Bradycardia

Atrioventricular Block

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area. Safety will be assessed by...

Eligibility Criteria

Inclusion

  • Patient is a candidate for implantation of a BIOTRONIK pacemaker system, per standard guidelines. Single chamber, dual chamber, and Cardiac Resynchronization Therapy with a Pacemaker (CRT-P) systems are allowed.
  • Patient has an implant planned to utilize left bundle branch area pacing within 30 days of consent
  • Patient is able to understand the nature of the study and provide written informed consent
  • Patient is available for follow-up visits on a regular basis for the expected duration of follow-up
  • Patient accepts Home Monitoring® concept
  • Patient age is greater than or equal to 18 years at time of consent

Exclusion

  • Patient meets a standard contraindication for pacemaker system implant
  • Patient is currently implanted with a pacemaker or Implantable Cardioverter-Defibrillator (ICD) device
  • Patient has had a previous unsuccessful attempt to place a lead in the LBB area
  • Patient has planned cardiac surgical procedures or interventional measures within 3 months after implant
  • Patient is expected to receive a heart transplant within 12 months
  • Patient life expectancy less than 12 months
  • Patient has the presence of another life-threatening, underlying illness separate from their cardiac disorder
  • Patient reports pregnancy at the time of enrollment
  • Patient is enrolled in any other investigational cardiac clinical study during the course of the study

Key Trial Info

Start Date :

December 12 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 8 2024

Estimated Enrollment :

194 Patients enrolled

Trial Details

Trial ID

NCT05251363

Start Date

December 12 2022

End Date

October 8 2024

Last Update

March 18 2025

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

Banner - University Medical Center Phoenix

Phoenix, Arizona, United States, 85006

2

Cardiology Associates Medical Group

Ventura, California, United States, 93003

3

Washington Hospital Center

Washington D.C., District of Columbia, United States, 20010

4

Sarasota Memorial Health Care System

Sarasota, Florida, United States, 34239